GlassScriptPhysician profile
Brittney Irons
NPI 1386103760
$2,091.81
in general payments reported to CMS, 2019-2025
14 companies · $272 in 2025
The $272 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $439 · 2022: $263 · 2023: $372 · 2024: $746 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $988 · Education: $402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $987.78 |
| Education | $402.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $682.82 | 2021-2025 | |
| Janssen Biotech, INC. | $573.46 | 2021-2025 | Tremfya, Simponi Aria, Simponi |
| Arcutis Biotherapeutics, INC. | $374.98 | 2023-2024 | Zoryve |
| Vyne Pharmaceuticals INC. | $155.59 | 2021 | |
| Sun Pharmaceutical Industries INC. | $86.02 | 2021-2024 | Ilumya |
| Pfizer INC. | $66.11 | 2021 | |
| Amgen INC. | $43.11 | 2022 | |
| Genentech USA, INC. | $19.60 | 2021 | |
| Biofrontera INC. | $18.63 | 2021 | |
| Glaxosmithkline, LLC. | $16.89 | 2022 | |
| Organon LLC | $16.47 | 2025 | Vtama |
| Incyte Corporation | $13.72 | 2021 | |
| Novartis Pharmaceuticals Corporation | $12.36 | 2022 | |
| Galderma Laboratories, L.P. | $12.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittney Irons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.